Skip to main content

Table 2 Resources available to support growth hormone treatment program by the size of participating centers

From: Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report

 

Total (73 responses)

Small centers (40 responses)

Large centers (33 responses)

p-value

Nutritional support for short children with pre-dialysis CKD, n (%)

 Renal dietitian

 Pediatric dietitian

 Pediatric nephrologist

50 (68.5)

9 (12.3)

15 (20.6)

20 (50.0)

7 (17.5)

13 (32.5)

30 (90.9)

1 (3.0)

2 (6.1)

0.001a

Role of endocrinology in rhGH management in CKD, n (%)

 Primary

 Initial consultation

 Challenging cases

 Rarely involved

19 (26.8)

4 (5.6)

11 (15.5)

37 (52.1)

17 (43.6)

3 (7.7)

6 (15.4)

13 (33.3)

2 (6.3)

1 (3.1)

5 (15.6)

24 (75.0)

<0.001a

Prior authorization for rhGH, n(%)

 Nurse

 Attending physician

 Other

55 (75.3)

8 (11.0)

10 (13.7)

28 (70.0)

3 (7.50)

9 (22.5)

27 (81.8)

5 (15.2)

1 (3.0)

0.04a

  1. aFisher’s exact test